Chicago, United States
MicroMGx, founded in 2015 and headquartered in the United States, is a pioneering entity in the Biotechnology and Health Care industries. The company’s vision is encapsulated in its slogan: "We harness the chemistry of microbes to create more effective and sustainable products."
The company distinguishes itself through its novel approach to rediscovering natural products. With many major pharmaceutical and agriculture companies scaling back on this front, MicroMGx leverages emerging technologies like metabolomics, genome sequencing, and bioinformatics to inject new value into this space. Notably, their team was the first to publish on the process of metabologenomics, marking a significant leap in product discovery paradigms.
MicroMGx's unique capability lies in its high-throughput means of discovery and development. By scaling metabologenomics and bioinformatics, they predict structures and activities of thousands of novel natural products, aligning innovation with sustainability.
As they expand the frontiers of microbial chemistry for clients, the absence of a disclosed last investment suggests an opportune moment for potential investors to engage early with a promising player reshaping traditional frameworks.
